Abstract
Whilst it is generally agreed that measurement of immunosuppressive drugs is of value as a guide to therapy, there are a number of problems associated with the analytical techniques available. Proficiency testing schemes enable laboratories to judge their performance for the measurement of these drugs with their peers. However, current schemes only compare accuracy within-methods to document performance. This paper summarizes current findings and points out the limitations of our own schemes, and the measures we intend to use to address these deficiencies.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 5 February 1999 · Accepted: 15 March 1999
Rights and permissions
About this article
Cite this article
Holt, D., Johnston, A. Delivering quality for the measurement of immunosuppressive drugs: current performance and future needs. Accred Qual Assur 4, 427–430 (1999). https://doi.org/10.1007/s007690050402
Issue Date:
DOI: https://doi.org/10.1007/s007690050402